As of 2026-04-07, the Relative Valuation of Karyopharm Therapeutics Inc (KPTI) is (201.49) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.32 USD, the upside of Karyopharm Therapeutics Inc based on Relative Valuation is -3288.1%.
The range of the Relative Valuation is (166.75) - (224.69) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.6x - 21.1x | 19.2x |
| Forward P/E multiples | 14.6x - 21.0x | 18.5x |
| Fair Price | (166.75) - (224.69) | (201.49) |
| Upside | -2738.5% - -3655.2% | -3288.1% |
| Date | P/E |
| 2026-04-06 | -0.59 |
| 2026-04-02 | -0.55 |
| 2026-04-01 | -0.54 |
| 2026-03-31 | -0.52 |
| 2026-03-30 | -0.50 |
| 2026-03-27 | -0.51 |
| 2026-03-26 | -0.52 |
| 2026-03-25 | -0.49 |
| 2026-03-24 | -0.51 |
| 2026-03-23 | -0.62 |
| 2026-03-20 | -0.71 |
| 2026-03-19 | -0.72 |
| 2026-03-18 | -0.79 |
| 2026-03-17 | -0.78 |
| 2026-03-16 | -0.80 |
| 2026-03-13 | -0.73 |
| 2026-03-12 | -0.74 |
| 2026-03-11 | -0.82 |
| 2026-03-10 | -0.77 |
| 2026-03-09 | -0.79 |
| 2026-03-06 | -0.82 |
| 2026-03-05 | -0.83 |
| 2026-03-04 | -0.86 |
| 2026-03-03 | -0.85 |
| 2026-03-02 | -0.90 |
| 2026-02-27 | -0.88 |
| 2026-02-26 | -0.87 |
| 2026-02-25 | -0.94 |
| 2026-02-24 | -0.94 |
| 2026-02-23 | -0.94 |
| 2026-02-20 | -0.90 |
| 2026-02-19 | -0.90 |
| 2026-02-18 | -0.87 |
| 2026-02-17 | -0.88 |
| 2026-02-13 | -0.80 |
| 2026-02-12 | -0.84 |
| 2026-02-11 | -0.69 |
| 2026-02-10 | -0.62 |
| 2026-02-09 | -0.59 |
| 2026-02-06 | -0.59 |
| 2026-02-05 | -0.57 |
| 2026-02-04 | -0.59 |
| 2026-02-03 | -0.61 |
| 2026-02-02 | -0.59 |
| 2026-01-30 | -0.61 |
| 2026-01-29 | -0.62 |
| 2026-01-28 | -0.65 |
| 2026-01-27 | -0.66 |
| 2026-01-26 | -0.62 |
| 2026-01-23 | -0.62 |